Valuation

Tscan Therapeutics, Inc. Valuation

Valuation for Tscan Therapeutics, Inc. (TCRX) on 6ix covers company data, market context, news, risks, and AI research briefs.

websiteTCRXValuation/analysis/TCRX/valuation

Tscan Therapeutics, Inc.

Tscan Therapeutics, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to TCRX.

Stock profile

Ticker

TCRX

Asset type

Stock

Market cap

$60.1M

Sector

Health Technology

Industry

Biotechnology

Currency

USD

Ticker listings

Tscan Therapeutics, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • TCRX primary listing

Research sections

Valuation

Review valuation context for Tscan Therapeutics, Inc..

Future growth

Review future growth context for Tscan Therapeutics, Inc..

Past performance

Review past performance context for Tscan Therapeutics, Inc..

Financial health

Review financial health context for Tscan Therapeutics, Inc..

Dividend

Review dividend context for Tscan Therapeutics, Inc..

Management

Review management context for Tscan Therapeutics, Inc..

Ownership

Review ownership context for Tscan Therapeutics, Inc..

Other information

Review other information context for Tscan Therapeutics, Inc..

Community

Review community context for Tscan Therapeutics, Inc..